Maximum Entertainment (MAXENT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Q4 2025 net sales declined 30% year-over-year to €17.8M, mainly due to cash restrictions impacting inventory and sales cycles.
Gross margin fell to 22% from 31% as the business shifted focus from Owned IP to licensed and sub-publishing.
Adjusted EBITDA was breakeven for Q4, down from €3.7M in Q4 2024; full-year adjusted EBITDA was €1.4M, down from €6.8M.
The company entered a restructuring term sheet with a key lender to address ongoing financial and operational challenges.
Board resolved to prepare a balance sheet for liquidation purposes after equity fell below half of registered share capital.
Financial highlights
Q4 2025 net sales: €17.8M (Q4 2024: €25.5M); full-year 2025: €62.1M (2024: €80.0M).
Q4 gross margin: 22% (Q4 2024: 31%); full-year: 25% (2024: 30%).
Q4 adjusted EBITDA: €0.0M (Q4 2024: €3.7M); full-year: €1.4M (2024: €6.8M).
Q4 EPS: -€1.30 (Q4 2024: -€0.09); full-year EPS: -€1.82 (2024: -€0.53).
Q4 cash flow from operations: -€0.1M (Q4 2024: €8.1M); year-end cash: €2.1M (2024: €6.1M).
Outlook and guidance
Focus for 2026 is on completing financial restructuring and rebuilding business foundations.
New partnerships and major IP launches (Winx, Starship Troopers, Thomas and Friends) expected in 2026.
Cost optimization and headcount reduction to continue.
Latest events from Maximum Entertainment
- Gross margin rose to 34% and adjusted EBITDA increased 15% YTD, with H2 set for major launches.MAXENT
Q2 20243 Feb 2026 - Net sales fell 26% to €25.5M amid restructuring, with legal and financing risks ongoing.MAXENT
Q4 20243 Feb 2026 - Sales and margins fell, but adjusted EBITDA improved; urgent financing and legal risks persist.MAXENT
Q3 20255 Nov 2025 - Sales and margins fell sharply, with liquidity and legal risks dominating the outlook.MAXENT
Q2 202513 Aug 2025 - Q3 2024 marked by lower sales, major impairments, and urgent financial restructuring.MAXENT
Q3 202413 Jun 2025 - Sales fell sharply and legal, financial risks persist despite cost cuts and new releases ahead.MAXENT
Q1 20256 Jun 2025